Table 1.
Target | Description |
---|---|
Carcinoembryonic antigen | Glycoprotein involved in cell adhesion, normally expressed during fetal development |
Human epithelial growth factor receptor 2 | Growth factor receptor belonging to human epithelial growth factor receptor family Overexpressed in 20%–30% of breast cancer cells, correlates with adverse prognosis |
MUC-1 | Membrane glycoprotein involved in immunologic and cell signaling functions Overexpressed in 70% of breast cancers |
hTERT | Component of the telomerase complex, a ribonucleoprotein that maintain chromosome integrity during cell proliferation and division |
p53 | Tumor suppressor protein, involved in cell cycle regulation and DNA damage repair Mutated in 20% of breast cancers |
Mammaglobin-A | Glycoprotein overexpressed in 80% of metastatic breast cancers |
Cancer testis antigens (NY-eso-1, MAGE, BAGE, and GAGE) | Proteins expressed in normal germ cells of the testis and embryonic ovaries and in certain types of cancer |
Abbreviations: TAAs, tumor-associated antigens; hTERT, telomerase reverse transcriptase; MUC-1, mucin-1.